About SunRegen
SunRegen is a clinical-stage Swiss biopharmaceutical company pioneering the development of SBC003, a first-in-class oral therapy with neuroprotective and neurorestorative potential across multiple neuronal indications, including Retinitis Pigmentosa (RP), dry AMD, Stroke, Alzheimer’s Disease, and Parkinson’s Disease etc. Supported by strong preclinical data, well-recognized science, and a clear path toward clinical development, we are building a world-class team to bring this transformative therapy to patients.
The Opportunity
We are seeking an experienced, strategic, and visionary Chief Medical Officer to lead the clinical development of SBC003 from Phase I through to registration. This is a foundational executive role with the opportunity to design and execute the global clinical strategy for a groundbreaking multi-indication asset. You will shape the therapeutic future of neurodegeneration and directly impact the company's trajectory toward becoming a commercial leader.
Key Responsibilities
Clinical Strategy & Leadership: Design and implement the overall clinical development plan (CDP) for SBC003 across all target indications (ophthalmic and CNS), ensuring scientific rigor, operational feasibility, and alignment with regulatory and commercial objectives.
Regulatory Leadership: Serve as the primary point of contact with global health authorities (FDA, EMA, etc.). Lead the preparation of all clinical regulatory submissions (IND/CTA, NDA/BLA/MAA). Strategically pursue and leverage expedited development pathways (Orphan Drug, Fast Track, PRIME, Breakthrough Therapy).
Trial Execution: Oversee the design, protocol development, and medical monitoring of all clinical trials (Phase I-III). Select and manage relationships with CROs, key opinion leaders (KOLs), and clinical sites to ensure high-quality, on-time, and on-budget delivery.
Medical & Safety Oversight: Provide medical expertise and oversight for all clinical activities. Chair the Safety Review Committee and be ultimately responsible for pharmacovigilance and patient safety across the development program.
Cross-Functional Leadership: Collaborate closely with the CSO on translational medicine, with the CEO on corporate strategy and fundraising, and with Commercial/BD on target product profile and life-cycle planning.
Data & Communication: Drive data analysis, interpretation, and communication. Author clinical study reports, present data at scientific conferences, and publish in peer-reviewed journals.
Qualifications & Experience
Medical Doctor (M.D.) or equivalent, board-certified in a relevant specialty (Neurology, Ophthalmology, or Internal Medicine preferred).
10+ years of proven, hands-on experience in global clinical drug development within the biotech/pharmaceutical industry, including significant CNS and/or ophthalmology experience.
Demonstrated success in leading programs from Phase I through to NDA/BLA submission and approval. Experience with orphan drug development and expedited regulatory pathways is highly desirable.
Strong existing relationships with global KOLs, clinical trial networks, and regulatory agencies.
Exceptional leadership, communication, and team-building skills, with the ability to thrive in a fast-paced, entrepreneurial environment.
Fluent in English.
What We Offer
A pivotal leadership role in a high-growth company with a transformative pipeline.
The opportunity to build and lead a clinical team and define the standard of care in neurodegeneration.
Competitive executive compensation package, including salary, performance bonus, and significant equity/stock option participation.
A dynamic, science-driven culture based in the heart of the European biotech hub in Basel.
To Apply
Please submit your CV and a cover letter outlining your relevant experience and motivation (in pdf format) to
[email protected]. Applications will be treated with strict confidentiality.
